Quick Answer
Ginkgo Bioworks Holdings, Inc. reported Diluted EPS of $5.64 per share (loss) for fiscal year 2025.
Ginkgo Bioworks Holdings, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$5.64 | +46.5% |
| 2024 | -$10.54 | +42.6% |
| 2023 | -$18.37 | +63.4% |
| 2022 | -$50.20 | -3511.5% |
| 2021 | -$1.39 | -1290.0% |
| 2020 | -$0.10 | +0.0% |
| 2019 | -$0.10 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.45 | -34.3% | -31.8% |
| June 30, 2025 | -$1.10 | +74.0% | +34.5% |
| March 31, 2025 | -$1.68 | +49.4% | -55.6% |
| September 30, 2024 | -$1.08 | +82.6% | +74.5% |
| June 30, 2024 | -$4.23 | -4600.0% | -27.4% |
| March 31, 2024 | -$3.32 | -2918.2% | +46.5% |
| September 30, 2023 | -$6.21 | -1414.6% | -6800.0% |
| June 30, 2023 | -$0.09 | +78.0% | +18.2% |
- Ginkgo Bioworks Holdings, Inc. showed an increase of +46.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Ginkgo Bioworks Holdings, Inc.’s diluted eps has declined by 5540.0% (from $0.10 per share (loss) to $5.64 per share (loss)).
- The most recent figure is from Ginkgo Bioworks Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: